Other Species / Isoforms
  NFAT3 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
-
gap
0 1
NFAT3 (human) gap -
NFAT3 iso10 (human) gap -
NFAT3 iso11 (human) LPSLLPAsLAsISHR S12-p
NFAT3 (mouse) gap -
NFAT3 (rat) gap -
-
gap
0 1
NFAT3 (human) gap -
NFAT3 iso10 (human) gap -
NFAT3 iso11 (human) LLPAsLAsISHRVTN S15-p
NFAT3 (mouse) gap -
NFAT3 (rat) gap -
S5
___MGAASCEDEELE
0 1
NFAT3 (human) ___MGAAsCEDEELE S5-p
NFAT3 iso10 (human) gap -
NFAT3 iso11 (human) AGSMGAASCEDEELE S68
NFAT3 (mouse) ___MGAASCEDEELE S5
NFAT3 (rat) ___MGAASCEDEELE S5
S73-p
PPRPGMHsPPPRPAP
0 2
NFAT3 (human) PPRPGMHsPPPRPAP S73-p
NFAT3 iso10 (human) PPRPGMHSPPPRPAP S61
NFAT3 iso11 (human) PPRPGMHSPPPRPAP S136
NFAT3 (mouse) PPRPGMHsPPPRPAP S73-p
NFAT3 (rat) PPRPGMHSPPPRPAP S73
S81-p
PPPRPAPsPGTWESQ
0 1
NFAT3 (human) PPPRPAPSPGTWESQ S81
NFAT3 iso10 (human) PPPRPAPSPGTWESQ S69
NFAT3 iso11 (human) PPPRPAPSPGTWESQ S144
NFAT3 (mouse) PPPRPAPsPGTWESQ S81-p
NFAT3 (rat) PPPRPAPSPGTWESQ S81
S120-p
CPSIRITsISPTPDP
0 1
NFAT3 (human) CPSIRITSISPTPEP S120
NFAT3 iso10 (human) CPSIRITSISPTPEP S108
NFAT3 iso11 (human) CPSIRITSISPTPEP S183
NFAT3 (mouse) CPSIRITsISPTPDP S120-p
NFAT3 (rat) CPSIRITSISPTPDP S120
S168-p
QGGGAFFsPsPGSSS
Upstream
Downstream
7 1
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • ERK5 (human)
  • mTOR (human)
  • P38A (human)
Putative in vivo kinases:
  • ERK5 (mouse)
  • mTOR (mouse)
  • P38A (mouse)
Regulatory protein:
  • ERK5 (mouse)
  • IRAK1 (mouse)
Treatment
  • calcineurin
  • calyculin_A
  • ciclosporin
  • FK520
  • HNMPA(AM)3
  • IL-18
  • ionomycin
  • ionomycin_withdrawal
  • isoproterenol
  • neuritin
  • okadaic_acid
  • Pam3CSK4
  • PD98059
  • rapamycin
  • SB203580
  • U0126
  • UV
  • wortmannin
NFAT3 (human) QGGGAFFsPsPGsSS S168-p
NFAT3 iso10 (human) QGGGAFFSPSPGSSS S156
NFAT3 iso11 (human) QGGGAFFSPSPGSSS S231
NFAT3 (mouse) QGGGAFFsPsPGSSS S168-p
NFAT3 (rat) QGGGAFFSPSPGSSS S168
S170-p
GGAFFsPsPGSSSLS
Upstream
Downstream
7 1
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • ERK5 (human)
  • mTOR (human)
  • P38A (human)
Putative in vivo kinases:
  • ERK5 (mouse)
  • mTOR (mouse)
  • P38A (mouse)
Regulatory protein:
  • ERK5 (mouse)
  • IRAK1 (mouse)
Treatment
  • calcineurin
  • calyculin_A
  • ciclosporin
  • FK520
  • HNMPA(AM)3
  • IL-18
  • ionomycin
  • ionomycin_withdrawal
  • isoproterenol
  • neuritin
  • okadaic_acid
  • Pam3CSK4
  • PD98059
  • rapamycin
  • SB203580
  • U0126
  • UV
  • wortmannin
NFAT3 (human) GGAFFsPsPGsSSLS S170-p
NFAT3 iso10 (human) GGAFFSPSPGSSSLS S158
NFAT3 iso11 (human) GGAFFSPSPGSSSLS S233
NFAT3 (mouse) GGAFFsPsPGSSSLS S170-p
NFAT3 (rat) GGAFFSPSPGSSSLS S170
S173
FFsPsPGSSSLSSWS
0 1
NFAT3 (human) FFsPsPGsSSLSSWS S173-p
NFAT3 iso10 (human) FFSPSPGSSSLSSWS S161
NFAT3 iso11 (human) FFSPSPGSSSLSSWS S236
NFAT3 (mouse) FFsPsPGSSSLSSWS S173
NFAT3 (rat) FFSPSPGSSSLSSWS S173
S212-p
AASRFGLssPLPsPR
Upstream
0 2
Treatment
  • insulin
NFAT3 (human) AASRFGLGsPLPsPR G212
NFAT3 iso10 (human) AASRFGLGSPLPSPR G200
NFAT3 iso11 (human) AASRFGLGSPLPSPR G275
NFAT3 (mouse) AASRFGLssPLPsPR S212-p
NFAT3 (rat) AASRFGLSSPLPsPR S212
S213-p
ASRFGLssPLPsPRA
Upstream
1 14
Treatment
  • insulin
  • LY294002
NFAT3 (human) ASRFGLGsPLPsPRA S213-p
NFAT3 iso10 (human) ASRFGLGSPLPSPRA S201
NFAT3 iso11 (human) ASRFGLGSPLPSPRA S276
NFAT3 (mouse) ASRFGLssPLPsPRA S213-p
NFAT3 (rat) ASRFGLSSPLPsPRA S213
S217-p
GLssPLPsPRASPRP
Upstream
1 17
Treatment
  • insulin
NFAT3 (human) GLGsPLPsPRAsPRP S217-p
NFAT3 iso10 (human) GLGSPLPSPRASPRP S205
NFAT3 iso11 (human) GLGSPLPSPRASPRP S280
NFAT3 (mouse) GLssPLPsPRASPRP S217-p
NFAT3 (rat) GLSSPLPsPRASPRP S217-p
S221
PLPsPRASPRPWtPE
0 4
NFAT3 (human) PLPsPRAsPRPWtPE S221-p
NFAT3 iso10 (human) PLPSPRASPRPWTPE S209
NFAT3 iso11 (human) PLPSPRASPRPWTPE S284
NFAT3 (mouse) PLPsPRASPRPWtPE S221
NFAT3 (rat) PLPsPRASPRPWTPE S221
T226-p
RASPRPWtPEDPWSL
0 11
NFAT3 (human) RAsPRPWtPEDPWSL T226-p
NFAT3 iso10 (human) RASPRPWTPEDPWSL T214
NFAT3 iso11 (human) RASPRPWTPEDPWSL T289
NFAT3 (mouse) RASPRPWtPEDPWSL T226-p
NFAT3 (rat) RASPRPWTPEDPWSL T226
Y234
PEDPWSLYGPSSGGR
0 1
NFAT3 (human) PEDPWSLyGPsPGGR Y234-p
NFAT3 iso10 (human) PEDPWSLYGPSPGGR Y222
NFAT3 iso11 (human) PEDPWSLYGPSPGGR Y297
NFAT3 (mouse) PEDPWSLYGPSSGGR Y234
NFAT3 (rat) PEDPWSLYGPSSGGR Y234
S237
PWSLYGPSSGGRAPE
0 2
NFAT3 (human) PWSLyGPsPGGRGPE S237-p
NFAT3 iso10 (human) PWSLYGPSPGGRGPE S225
NFAT3 iso11 (human) PWSLYGPSPGGRGPE S300
NFAT3 (mouse) PWSLYGPSSGGRAPE S237
NFAT3 (rat) PWSLYGPSSGGRAPE S237
S246
GGRAPEDSWLLLSAP
0 1
NFAT3 (human) GGRGPEDsWLLLSAP S246-p
NFAT3 iso10 (human) GGRGPEDSWLLLSAP S234
NFAT3 iso11 (human) GGRGPEDSWLLLSAP S309
NFAT3 (mouse) GGRAPEDSWLLLSAP S246
NFAT3 (rat) GGRAPEDSWLLLSAP S246
V256
LLSAPGPVPASPRPA
0 2
NFAT3 (human) LLSAPGPtPAsPRPA T256-p
NFAT3 iso10 (human) LLSAPGPTPASPRPA T244
NFAT3 iso11 (human) LLSAPGPTPASPRPA T319
NFAT3 (mouse) LLSAPGPVPASPRPA V256
NFAT3 (rat) LLSAPGPIPASPRPA I256
S259
APGPVPASPRPAsPC
1 1
NFAT3 (human) APGPtPAsPRPAsPC S259-p
NFAT3 iso10 (human) APGPTPASPRPASPC S247
NFAT3 iso11 (human) APGPTPASPRPASPC S322
NFAT3 (mouse) APGPVPASPRPAsPC S259
NFAT3 (rat) APGPIPASPRPAsPC S259
S264-p
PASPRPAsPCGKRRY
0 11
NFAT3 (human) PAsPRPAsPCGKRRY S264-p
NFAT3 iso10 (human) PASPRPASPCGKRRY S252
NFAT3 iso11 (human) PASPRPASPCGKRRY S327
NFAT3 (mouse) PASPRPAsPCGKRRY S264-p
NFAT3 (rat) PASPRPAsPCGKRRY S264-p
S272-p
PCGKRRYsSsGTPSS
Upstream
0 13
Treatment
  • insulin
  • MK-2206
  • PTH(1-34)
NFAT3 (human) PCGKRRYsSSGTPSS S272-p
NFAT3 iso10 (human) PCGKRRYSSSGTPSS S260
NFAT3 iso11 (human) PCGKRRYSSSGTPSS S335
NFAT3 (mouse) PCGKRRYsSsGTPSS S272-p
NFAT3 (rat) PCGKRRYSSSGTPSS S272
S274-p
GKRRYsSsGTPSSAS
0 1
NFAT3 (human) GKRRYsSSGTPSSAs S274
NFAT3 iso10 (human) GKRRYSSSGTPSSAS S262
NFAT3 iso11 (human) GKRRYSSSGTPSSAS S337
NFAT3 (mouse) GKRRYsSsGTPSSAS S274-p
NFAT3 (rat) GKRRYSSSGTPSSAS S274
S281
sGTPSSASPALSRRG
1 3
NFAT3 (human) SGTPSSAsPALsRRG S281-p
NFAT3 iso10 (human) SGTPSSASPALSRRG S269
NFAT3 iso11 (human) SGTPSSASPALSRRG S344
NFAT3 (mouse) sGTPSSASPALSRRG S281
NFAT3 (rat) SGTPSSASPALSRRG S281
S285
SSASPALSRRGsLGE
1 1
NFAT3 (human) SSAsPALsRRGsLGE S285-p
NFAT3 iso10 (human) SSASPALSRRGSLGE S273
NFAT3 iso11 (human) SSASPALSRRGSLGE S348
NFAT3 (mouse) SSASPALSRRGsLGE S285
NFAT3 (rat) SSASPALSRRGsLGE S285
S289-p
PALSRRGsLGEEGPE
1 24
NFAT3 (human) PALsRRGsLGEEGsE S289-p
NFAT3 iso10 (human) PALSRRGSLGEEGSE S277
NFAT3 iso11 (human) PALSRRGSLGEEGSE S352
NFAT3 (mouse) PALSRRGsLGEEGPE S289-p
NFAT3 (rat) PALSRRGsLGEEGPE S289-p
P295
GsLGEEGPEPPPPPP
0 3
NFAT3 (human) GsLGEEGsEPPPPPP S295-p
NFAT3 iso10 (human) GSLGEEGSEPPPPPP S283
NFAT3 iso11 (human) GSLGEEGSEPPPPPP S358
NFAT3 (mouse) GsLGEEGPEPPPPPP P295
NFAT3 (rat) GsLGEEGPEPPPPPP P295
S311
PLVRDPSSPGPFDYV
0 8
NFAT3 (human) PLARDPGsPGPFDyV S311-p
NFAT3 iso10 (human) PLARDPGSPGPFDYV S299
NFAT3 iso11 (human) PLARDPGSPGPFDYV S374
NFAT3 (mouse) PLVRDPSSPGPFDYV S311
NFAT3 (rat) PLVRDPSSSGPFDYV S311
Y317
SSPGPFDYVGAPPTE
0 1
NFAT3 (human) GsPGPFDyVGAPPAE Y317-p
NFAT3 iso10 (human) GSPGPFDYVGAPPAE Y305
NFAT3 iso11 (human) GSPGPFDYVGAPPAE Y380
NFAT3 (mouse) SSPGPFDYVGAPPTE Y317
NFAT3 (rat) SSSGPFDYVGAPPTE Y317
T333
IPQKTRRTsSEQAVA
0 2
NFAT3 (human) IPQKTRRtssEQAVA T333-p
NFAT3 iso10 (human) IPQKTRRTSSEQAVA T321
NFAT3 iso11 (human) IPQKTRRTSSEQAVA T396
NFAT3 (mouse) IPQKTRRTsSEQAVA T333
NFAT3 (rat) VPQKTRRTsSEQAVA T333
S334-p
PQKTRRTsSEQAVAL
Upstream
0 15
Treatment
  • insulin
  • PTH(1-34)
NFAT3 (human) PQKTRRtssEQAVAL S334-p
NFAT3 iso10 (human) PQKTRRTSSEQAVAL S322
NFAT3 iso11 (human) PQKTRRTSSEQAVAL S397
NFAT3 (mouse) PQKTRRTsSEQAVAL S334-p
NFAT3 (rat) PQKTRRTsSEQAVAL S334-p
S335
QKTRRTsSEQAVALP
0 3
NFAT3 (human) QKTRRtssEQAVALP S335-p
NFAT3 iso10 (human) QKTRRTSSEQAVALP S323
NFAT3 iso11 (human) QKTRRTSSEQAVALP S398
NFAT3 (mouse) QKTRRTsSEQAVALP S335
NFAT3 (rat) QKTRRTsSEQAVALP S335
S344
QAVALPRSEEPPSCN
1 2
NFAT3 (human) QAVALPRsEEPASCN S344-p
NFAT3 iso10 (human) QAVALPRSEEPASCN S332
NFAT3 iso11 (human) QAVALPRSEEPASCN S407
NFAT3 (mouse) QAVALPRSEEPPSCN S344
NFAT3 (rat) QAVALPRSEEPASCN S344
S382-p
MDYLAVPsPLAWSKA
0 2
NFAT3 (human) MDYLAVPsPLAWSKA S382-p
NFAT3 iso10 (human) MDYLAVPSPLAWSKA S370
NFAT3 iso11 (human) MDYLAVPSPLAWSKA S445
NFAT3 (mouse) MDYLAVPsPLAWSKA S382-p
NFAT3 (rat) MDYLAVPSPLAWSKA S382
Y653
LTLTIPEYSNKRVSR
0 1
NFAT3 (human) LTLTVPEysNKRVSR Y653-p
NFAT3 iso10 (human) LTLTVPEYSNKRVSR Y641
NFAT3 iso11 (human) LTLTVPEYSNKRVSR Y716
NFAT3 (mouse) LTLTIPEYSNKRVSR Y653
NFAT3 (rat) LTLTIPEYSNKRVSR Y653
S654
TLTIPEYSNKRVSRP
0 1
NFAT3 (human) TLTVPEysNKRVSRP S654-p
NFAT3 iso10 (human) TLTVPEYSNKRVSRP S642
NFAT3 iso11 (human) TLTVPEYSNKRVSRP S717
NFAT3 (mouse) TLTIPEYSNKRVSRP S654
NFAT3 (rat) TLTIPEYSNKRVSRP S654
S676-p
SNGRRKRsPTQSFKF
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, induced
  • intracellular localization
Effects on Biological Processes:
  • transcription, altered
Putative in vivo kinases:
  • ERK1 (mouse)
  • ERK2 (mouse)
Treatment
  • IL-18
  • PD98059
  • SB203580
  • siRNA
  • SP600125
NFAT3 (human) SNGRRKRsPTQSFRF S676-p
NFAT3 iso10 (human) SNGRRKRSPTQSFRF S664
NFAT3 iso11 (human) SNGRRKRSPTQSFRF S739
NFAT3 (mouse) SNGRRKRsPTQSFKF S676-p
NFAT3 (rat) SNGRRKRSPTQSFKF S676
T772
FPETGGTTGCARLPS
0 1
NFAT3 (human) FPETRGTtGCAQPPA T772-p
NFAT3 iso10 (human) FPETRGTTGCAQPPA T760
NFAT3 iso11 (human) FPETRGTTVSEIIGR T835
NFAT3 (mouse) FPETGGTTGCARLPS T772
NFAT3 (rat) FPETGGTTGCARLPS T772
K857
EGASEQEKARGGYSS
0 1
NFAT3 (human) EGAPEQEkSRGGYSS K858-ub
NFAT3 iso10 (human) EGAPEQEKSRGGYSS K846
NFAT3 iso11 (human) gap -
NFAT3 (mouse) EGASEQEKARGGYSS K857
NFAT3 (rat) EGASEQEKSRGGYGS K857